tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cohort plc Directors Adjust Shareholdings

Story Highlights
Cohort plc Directors Adjust Shareholdings

Elevate Your Investing Strategy:

Cohort plc ( (GB:CHRT) ) just unveiled an announcement.

Cohort plc announced the sale of ordinary shares by its Chairman, Nick Prest, and Executive Directors, Andrew Thomis and Simon Walther, along with their closely associated persons. The transactions, conducted on July 16, 2025, involved a total of 560,102 shares sold at 1743.24 pence each. Despite these sales, the directors maintain their minimum shareholding requirements, ensuring their alignment with shareholder interests. This move reflects a routine adjustment in personal shareholdings and does not impact the company’s strategic direction or operational stability.

The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Spark’s Take on GB:CHRT Stock

According to Spark, TipRanks’ AI Analyst, GB:CHRT is a Outperform.

Cohort plc’s overall stock score is strong, driven by robust financial performance and positive corporate events. The technical analysis indicates a bullish trend but warns of potential short-term risks. Valuation concerns slightly temper the outlook.

To see Spark’s full report on GB:CHRT stock, click here.

More about Cohort plc

Cohort plc is a parent company of seven innovative businesses based in the UK, Australia, Germany, and Portugal, providing a wide range of services and products for domestic and export customers in defense and related markets. The company operates in two segments: Communications and Intelligence, and Sensors and Effectors, with notable subsidiaries like EID, EM Solutions, and MASS, serving naval, military, and security markets.

Average Trading Volume: 221,622

Technical Sentiment Signal: Buy

Current Market Cap: £700.6M

See more insights into CHRT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1